Inaugural Multidisciplinary CNS Metastasis Update
The goal of this educational activity is to present a multidisciplinary approach to the clinical management of CNS metastasis from various cancers, discuss available innovative clinical trial options and provide the latest updates on current techniques in neurosurgical advancements in this arena. Using a disease-orientated multiple specialty approach along with panel discussions, the activity will provide a comprehensive update for providers from multiple disciplines.
Physicians and other healthcare providers locally, regionally and nationally will learn about novel advances in the treatment and management of brain and spine metastasis from common cancers encountered in daily practice. Participation is encouraged through question and answer opportunities during the program.
Practice Gaps and Needs
Multidisciplinary CNS metastasis update is the first, one of its kind, premier educational event in the region designed to educate a broader oncology committee involved in caring for cancer patients with brain and spine metastasis. Given the unique circumstances this year due to COVID-19, we will also discuss the effect of COVID-19 on oncological care in our community. This course will provide a comprehensive review and update of medical oncology core competencies as outlined by the Medical Oncology Certification Board, as well as instruction on innovations in technology and medical care focused on improved outcomes for patients.
Elements of Competence
This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties' areas of patient care and procedural skills, medical knowledge, and interpersonal and communication skills.
This activity also focuses on the interprofessional competencies of roles/responsibilities, interprofessional communication, and teams/teamwork.
Intended Audience
This activity is designed to educate community general practitioners, oncologists, radiation oncologists, neurosurgeons, advanced practice nurses, PAs, RNs and other healthcare providers on topics relevant to new advances in the diagnosis and treatment of brain and spine metastasis from cancer.
Highlights include:
- Updates of minimally invasive neurosurgery
- Updates of medical/radiation oncology clinical trials
- COVID-19 effect on oncological care
Learning Objectives
At the conclusion of this CE activity, participants will be able to:
- Discuss communication and collaboration with partners in care of patients.
- Review best current multi-disciplinary treatment strategy for cancer patients with brain and spine metastasis.
- Discuss effective patient centric practice management techniques.
Provided by
University of Wisconsin School of Medicine and Public Health
Department of Neurological Surgery
![]() |
In Cooperation With
![]() |
Saturday, October 17, 2020 | |
| |
7:45 AM | Welcome |
Neurological Update | |
8:00 AM | Stereotactic Radiosurgery for Brain Metastasis |
8:45 AM | Minimally Invasive Surgical Options for Treatment of Brain Metastasis |
9:00 AM | Open Surgery for Brain Metastasis |
9:15 AM | Spine Tumor Management |
9:30 AM | Panel Discussion |
9:45 AM | BREAK |
Oncological Update | |
10:00 AM | Updates on Breast Cancer Brain Metastases |
10:45 AM | Advances in the Management of CNS Metastasis from Lung Cancer |
11:00 AM | Radiosurgery in the Era of Targeted Systemic and Immunotherapies |
11:15 AM | CNS Metastasis as Exclusion Criteria |
11:30 AM | Panel Discussion |
12:00 PM | BREAK |
Radiology Oncology Update | |
1:00 PM | Advances in Brain Metastases Management |
1:45 PM | Whole Brain Re-irradiation in the Management of Recurrent Metastasis |
2:00 PM | Radiosurgery Physics and Treatment Technology |
2:15 PM | Overview of Brain Metastasis Research at the University of Wisconsin |
2:30 PM | Panel Discussion |
2:45 PM | BREAK |
Patient Care Center | |
3:00 PM | COVID-19 and Cancer Care at UWCCC |
3:15 PM | Palliative Care as part of the interdisciplinary management of patients with brain metastases: Models of Early Palliative Care |
3:45 PM | Patient Centric Comprehensive Care |
4:00 PM | Panel Discussion |
4:30 PM | ADJOURN |
THIS IS A VIRTUAL CONFERENCE (CENTRAL DAYLIGHT TIME). PLEASE SEE THE PROGRAM FOR FURTHER INFORMATION.
A LINK TO THE WEBINAR WILL BE SENT TO PARTICIPANTS PRIOR TO THE ACTIVITY START DATE.
Course Director
Mahua Dey, MD; Assistant Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Visiting Faculty
Carey Anders, MD; Medical Director of the Brain and Spine Metastases Program, Professor of Medicine, Duke University School of Medicine, Durham, NC
Joseph Bovi, MD; MCW, Professor of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI
Michael McDermott, MD; Chief Medical Executive of Miami Neuroscience Institute, Professor of Neurosurgery, Baptist Health South Florida, Miami, FL
University of Wisconsin Faculty
Andrew Baschnagel, MD; Human Oncology Director of Clinical Trials, Associate Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health
Mustafa Baskaya, MD; Director of Skull Base Surgery, Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Michael Bassetti, MD, PhD; Assistant Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health
Nathaniel Brooks, MD; Associate Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Toby Campbell, MD, MSCI; Professor & Chief of Palliative Care, Thoracic Medical Oncology, University of Wisconsin School of Medicine and Public Health
Demi Dawkins, MD; Honorary Associate/Fellow of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Robert Dempsey, MD; Manucher Javid Professor and Chairman of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Mahua Dey, MD; Director of Surgical Neuro-oncology, Assistant Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Narjust Duma, MD; Assistant Professor of Medicine, University of Wisconsin School of Medicine and Public Health
Steven Howard, MD, PhD; Associate Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health
Dustin Jacqmin, PhD; Assistant Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health
Zacariah (Zac) Labby, PhD, DABR; Assistant Professor of Human Oncology, University of Wisconsin School of Medicine and Public Health
Ticiana A. Leal, MD; Director of Thoracic Medical Oncology, Assistant Professor of Medicine, University of Wisconsin School of Medicine and Public Health
Jessica Leiberg, DNP; Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Ruth O'Regan, MD; Deputy Director of UWCCC and Division Head of Hematology and Oncology, Professor of Medicine, University of Wisconsin School of Medicine and Public Health
Angela Richardson, MD, PhD; Clinical Instructor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Planning Committee
Mahua Dey, MD; Assistant Professor of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Jessica Leiberg, NP; Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health
Ruth O'Regan, MD; Professor of Medicine, University of Wisconsin School of Medicine and Public Health
Terese Bailey, BS; Senior Outreach Specialist, Office of Continuing Development, University of Wisconsin–Madison ICEP
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below.
Name of Individual | Individual’s Role | Name of Commercial Interest & Nature of Relationship | Discussion of |
Cary Anders, MD | Speaker | Eisai, Genentech, Novartis, AstraZeneca, Ipsen Biopharmaceuticals, Inc., Seattle Genetics (Contractor); Eli Lilly and Company, TESARO, Inc., Puma, Merck, Novartis, Pfizer, G1-therapeutics, Zion Pharma, Seattle Genetics, Nektar (Grant); Jones and Bartlett Publishing, Up to date (Other IP) | Yes |
Terese Bailey, BS | Planner | No relevant financial relationships to disclose | No |
Andrew Baschnagel, MD | Speaker | No relevant financial relationships to disclose | No |
Mustafa Baskaya, MD | Speaker | No relevant financial relationships to disclose | No |
Michael Bassetti, MD, PhD | Speaker | EMD Serono, Merck, AstraZeneca (Grant) | No |
Joseph Bovi, MD | Speaker | No relevant financial relationships to disclose | No |
Nathaniel Brooks, MD | Speaker | No relevant financial relationships to disclose | No |
Toby Campbell, MD, MS | Speaker | No relevant financial relationships to disclose | No |
Demi Dawkins, MD | Moderator | No relevant financial relationships to disclose | No |
Robert Dempsey, MD | Speaker | No relevant financial relationships to disclose | No |
Mahua Dey, MD | Course Director, Speaker, Moderator | No relevant financial relationships to disclose | No |
Narjust Duma, MD | Speaker | Inivata, Inc., AstraZeneca (Contractor) | No |
Steven Howard, MD, PhD | Speaker | No relevant financial relationships to disclose | No |
Dustin Jacqmin, PhD | Moderator | American Society for Radiation Oncology, Asto CT, Inc. (Contractor) | No |
Zacariah (Zac) Labby, PhD | Speaker | No relevant financial relationships to disclose | No |
Ticiana Leal, MD | Speaker | Genentech USA, Inc., Merck, EMD Serono, Inc., Jazz Pharmaceuticals Inc., Takeda Oncology, AstraZeneca, Inivata, Novocurre Israel Ltd. (Contractor) | No |
Jessica Leiberg, DNP | Planner, Speaker | No relevant financial relationships to disclose | No |
Michael McDermott, MD | Speaker | Deinde Medical (Contractor) | No |
Ruth O’Regan, MD | Planner, Speaker | Macrogenics, Eli Lilly and Company, Genomic Health, Biotheranostis, Genentech, PUMA (Contractor); Genomic Health, Eli Lilly and Company (Travel) | No |
Angela Richardson, MD, PhD | Moderator | Stryker Corporation (Contractor) | No |
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Accreditation Statement
![]() | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
CREDIT DESIGNATION STATEMENTS
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 7.0 ANCC contact hours.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. Iowa Board of Nursing accepts ANCC contact hours for nursing continuing education requirements.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison, as a member of the University Professional Continuing Education Association (UPCEA), authorizes this program for 0.7 continuing education units (CEUs) or 7.0 hours.
Available Credit
- 7.00 AMA PRA Category 1 Credit™
- 7.00 ANCC Contact Hours
- 7.00 University of Wisconsin–Madison Continuing Education Hours
Registration Fees
$50.00 MD/DO
$25.00 Other healthcare providers
$0.00 Trainees, including fellows, residents and students
Syllabus Materials
Syllabus materials will be posted on this site. Materials will be available to registered participants 48 hours (October 22) prior to the event. If you want to view the presentations while at the conference, please bring your laptop.
CANCELLATION AND REFUND POLICY
Requests for cancellation must be submitted in writing to help@icep.wisc.edu. Cancellation requests received at least 96 hours prior to the conference will allow a full refund except for the $10 nonrefundable processing fee. No refunds will be made for cancellations received less than 96 hours prior to the activity start date.
PROGRAM CHANGES
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
For Further Information
For conference information or details, please contact Mahua Dey, MD by emailing whiting@neurosurgery.wisc.edu.